Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
Rush University Medical Center
mi
from
Chicago, IL
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
Children's Hospital - Boston
mi
from
Boston, MA
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
Children's Hospital - Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
University of New Mexico
mi
from
Albuquerque, NM
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
University Hospitals of Cleveland
mi
from
Cleveland, OH
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
University of Virginia Health System
mi
from
Charlottesville, VA
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
University of Wisconsin
mi
from
Madison, WI
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated:  10/30/2012
Center for Urban Population Health
mi
from
Milwaukee, WI
Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children
Status: Enrolling
Updated: 10/30/2012
Center for Urban Population Health
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Novel Unidirectional Face Mask During Noninvasive Positive Pressure Ventilation (NPPV) in Chronic Obstructive Pulmonary Disease (COPD) Patients
Use of a Novel Unidirectional Face Mask During Noninvasive Positive Pressure Ventilation (NPPV) in Chronic Obstructive Pulmonary Disease (COPD) Patients
Status: Enrolling
Updated:  11/5/2012
Massachusetts General Hospital
mi
from
Boston, MA
A Novel Unidirectional Face Mask During Noninvasive Positive Pressure Ventilation (NPPV) in Chronic Obstructive Pulmonary Disease (COPD) Patients
Use of a Novel Unidirectional Face Mask During Noninvasive Positive Pressure Ventilation (NPPV) in Chronic Obstructive Pulmonary Disease (COPD) Patients
Status: Enrolling
Updated: 11/5/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin
Status: Enrolling
Updated:  11/6/2012
The Center for Learning and Health
mi
from
Baltimore, MD
Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin
Status: Enrolling
Updated: 11/6/2012
The Center for Learning and Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated:  11/13/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated: 11/13/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated:  11/13/2012
Clinical Research Facility
mi
from
Decatur, GA
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated: 11/13/2012
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated:  11/13/2012
Clinical Research Facility
mi
from
Park Ridge, IL
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated: 11/13/2012
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated:  11/13/2012
Clinical Research Facility
mi
from
Boston, MA
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated: 11/13/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated:  11/13/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated: 11/13/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated:  11/13/2012
Clinical Research Facility
mi
from
Rochester, MN
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated: 11/13/2012
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated:  11/13/2012
Clinical Research Facility
mi
from
St. Joseph, MO
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated: 11/13/2012
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated:  11/13/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated: 11/13/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated:  11/13/2012
Clinical Research Facility
mi
from
Dallas, TX
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation
Status: Enrolling
Updated: 11/13/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Viral Triggers in Pediatric Lung Transplantation
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (CTOTC-03)
Status: Enrolling
Updated:  11/14/2012
Stanford University
mi
from
Stanford, CA
Viral Triggers in Pediatric Lung Transplantation
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (CTOTC-03)
Status: Enrolling
Updated: 11/14/2012
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Viral Triggers in Pediatric Lung Transplantation
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (CTOTC-03)
Status: Enrolling
Updated:  11/14/2012
Washington University
mi
from
St.Louis, MO
Viral Triggers in Pediatric Lung Transplantation
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (CTOTC-03)
Status: Enrolling
Updated: 11/14/2012
Washington University
mi
from
St.Louis, MO
Click here to add this to my saved trials
Viral Triggers in Pediatric Lung Transplantation
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (CTOTC-03)
Status: Enrolling
Updated:  11/14/2012
Nationwide Children's Hospital
mi
from
Columbus, OH
Viral Triggers in Pediatric Lung Transplantation
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (CTOTC-03)
Status: Enrolling
Updated: 11/14/2012
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Viral Triggers in Pediatric Lung Transplantation
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (CTOTC-03)
Status: Enrolling
Updated:  11/14/2012
Children's Hospital of Pennsylvania
mi
from
Philadelphia, PA
Viral Triggers in Pediatric Lung Transplantation
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (CTOTC-03)
Status: Enrolling
Updated: 11/14/2012
Children's Hospital of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Viral Triggers in Pediatric Lung Transplantation
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (CTOTC-03)
Status: Enrolling
Updated:  11/14/2012
Texas Children's Hospital
mi
from
Houston, TX
Viral Triggers in Pediatric Lung Transplantation
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (CTOTC-03)
Status: Enrolling
Updated: 11/14/2012
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Stepping up to Health - for Veterans With Chronic Obstructive Pulmonary Disease (COPD)
Effectiveness of an Automated Walking Program Targeting Veterans With COPD
Status: Enrolling
Updated:  11/14/2012
VA Ann Arbor Healthcare System
mi
from
Ann Arbor, MI
Stepping up to Health - for Veterans With Chronic Obstructive Pulmonary Disease (COPD)
Effectiveness of an Automated Walking Program Targeting Veterans With COPD
Status: Enrolling
Updated: 11/14/2012
VA Ann Arbor Healthcare System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease
Randomised, Double-blind, Placebo-controlled, 6 Treatment, 4 Period, Incomplete Cross-over Trial to Characterise the 24-hour Lung Function Profiles of Tiotropium + Olodaterol Fixed Dose Combination (Low Dose, High Dose), Tiotropium (Low Dose, High Dose) and Olodaterol (One Dose Only) (Oral Inhalation, Delivered by the RESPIMAT Inhaler) After 6 Weeks Once Daily Treatment in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  11/14/2012
205.440.1015 Boehringer Ingelheim Investigational Site
mi
from
Jasper, AL
Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease
Randomised, Double-blind, Placebo-controlled, 6 Treatment, 4 Period, Incomplete Cross-over Trial to Characterise the 24-hour Lung Function Profiles of Tiotropium + Olodaterol Fixed Dose Combination (Low Dose, High Dose), Tiotropium (Low Dose, High Dose) and Olodaterol (One Dose Only) (Oral Inhalation, Delivered by the RESPIMAT Inhaler) After 6 Weeks Once Daily Treatment in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 11/14/2012
205.440.1015 Boehringer Ingelheim Investigational Site
mi
from
Jasper, AL
Click here to add this to my saved trials
Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease
Randomised, Double-blind, Placebo-controlled, 6 Treatment, 4 Period, Incomplete Cross-over Trial to Characterise the 24-hour Lung Function Profiles of Tiotropium + Olodaterol Fixed Dose Combination (Low Dose, High Dose), Tiotropium (Low Dose, High Dose) and Olodaterol (One Dose Only) (Oral Inhalation, Delivered by the RESPIMAT Inhaler) After 6 Weeks Once Daily Treatment in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  11/14/2012
1268.17.01031 Boehringer Ingelheim Investigational Site
mi
from
Easley, SC
Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease
Randomised, Double-blind, Placebo-controlled, 6 Treatment, 4 Period, Incomplete Cross-over Trial to Characterise the 24-hour Lung Function Profiles of Tiotropium + Olodaterol Fixed Dose Combination (Low Dose, High Dose), Tiotropium (Low Dose, High Dose) and Olodaterol (One Dose Only) (Oral Inhalation, Delivered by the RESPIMAT Inhaler) After 6 Weeks Once Daily Treatment in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 11/14/2012
1268.17.01031 Boehringer Ingelheim Investigational Site
mi
from
Easley, SC
Click here to add this to my saved trials
Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease
Randomised, Double-blind, Placebo-controlled, 6 Treatment, 4 Period, Incomplete Cross-over Trial to Characterise the 24-hour Lung Function Profiles of Tiotropium + Olodaterol Fixed Dose Combination (Low Dose, High Dose), Tiotropium (Low Dose, High Dose) and Olodaterol (One Dose Only) (Oral Inhalation, Delivered by the RESPIMAT Inhaler) After 6 Weeks Once Daily Treatment in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  11/14/2012
Boehringer Ingelheim Investigational Site
mi
from
Greenville, SC
Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease
Randomised, Double-blind, Placebo-controlled, 6 Treatment, 4 Period, Incomplete Cross-over Trial to Characterise the 24-hour Lung Function Profiles of Tiotropium + Olodaterol Fixed Dose Combination (Low Dose, High Dose), Tiotropium (Low Dose, High Dose) and Olodaterol (One Dose Only) (Oral Inhalation, Delivered by the RESPIMAT Inhaler) After 6 Weeks Once Daily Treatment in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 11/14/2012
Boehringer Ingelheim Investigational Site
mi
from
Greenville, SC
Click here to add this to my saved trials
Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease
Randomised, Double-blind, Placebo-controlled, 6 Treatment, 4 Period, Incomplete Cross-over Trial to Characterise the 24-hour Lung Function Profiles of Tiotropium + Olodaterol Fixed Dose Combination (Low Dose, High Dose), Tiotropium (Low Dose, High Dose) and Olodaterol (One Dose Only) (Oral Inhalation, Delivered by the RESPIMAT Inhaler) After 6 Weeks Once Daily Treatment in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  11/14/2012
Boehringer Ingelheim Investigational Site
mi
from
Spartanburg, SC
Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease
Randomised, Double-blind, Placebo-controlled, 6 Treatment, 4 Period, Incomplete Cross-over Trial to Characterise the 24-hour Lung Function Profiles of Tiotropium + Olodaterol Fixed Dose Combination (Low Dose, High Dose), Tiotropium (Low Dose, High Dose) and Olodaterol (One Dose Only) (Oral Inhalation, Delivered by the RESPIMAT Inhaler) After 6 Weeks Once Daily Treatment in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 11/14/2012
Boehringer Ingelheim Investigational Site
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.
Status: Enrolling
Updated:  11/28/2012
University of Michigan
mi
from
Ann Arbor, MI
Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.
Status: Enrolling
Updated: 11/28/2012
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Pulmozyme in Cystic Fibrosis With Sinusitis
Z4770s, Use of Recombinant Human DNASE in Cystic Fibrosis Patients With Chronic Sinusitis to Prevent Acute Sinusitis Exacerbations and Improve Symptoms and Outcomes - A Pilot Study
Status: Enrolling
Updated:  11/29/2012
Penn State Unicersity
mi
from
Hershey, PA
Pulmozyme in Cystic Fibrosis With Sinusitis
Z4770s, Use of Recombinant Human DNASE in Cystic Fibrosis Patients With Chronic Sinusitis to Prevent Acute Sinusitis Exacerbations and Improve Symptoms and Outcomes - A Pilot Study
Status: Enrolling
Updated: 11/29/2012
Penn State Unicersity
mi
from
Hershey, PA
Click here to add this to my saved trials
Bipap autoSV Advanced in Central Apnea Patients
BiPAP autoSV Advanced in Central Apnea Patients, ST-1001-ASVWO-MS
Status: Enrolling
Updated:  11/30/2012
Gaylord Hospital - Gaylord Sleep Research
mi
from
Wallingford, CT
Bipap autoSV Advanced in Central Apnea Patients
BiPAP autoSV Advanced in Central Apnea Patients, ST-1001-ASVWO-MS
Status: Enrolling
Updated: 11/30/2012
Gaylord Hospital - Gaylord Sleep Research
mi
from
Wallingford, CT
Click here to add this to my saved trials
Bipap autoSV Advanced in Central Apnea Patients
BiPAP autoSV Advanced in Central Apnea Patients, ST-1001-ASVWO-MS
Status: Enrolling
Updated:  11/30/2012
Kentucky Research Group
mi
from
Louisville, KY
Bipap autoSV Advanced in Central Apnea Patients
BiPAP autoSV Advanced in Central Apnea Patients, ST-1001-ASVWO-MS
Status: Enrolling
Updated: 11/30/2012
Kentucky Research Group
mi
from
Louisville, KY
Click here to add this to my saved trials
Bipap autoSV Advanced in Central Apnea Patients
BiPAP autoSV Advanced in Central Apnea Patients, ST-1001-ASVWO-MS
Status: Enrolling
Updated:  11/30/2012
Sleepcare Diagnostics
mi
from
Mason, OH
Bipap autoSV Advanced in Central Apnea Patients
BiPAP autoSV Advanced in Central Apnea Patients, ST-1001-ASVWO-MS
Status: Enrolling
Updated: 11/30/2012
Sleepcare Diagnostics
mi
from
Mason, OH
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
Best Medical Group
mi
from
Phoenix, AZ
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
Best Medical Group
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
Santo Nino Medical Clinic
mi
from
Panorama City, CA
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
Santo Nino Medical Clinic
mi
from
Panorama City, CA
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
Gentle Medical Associates
mi
from
Boynton Beach, FL
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
Gentle Medical Associates
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
Genesis Community Health
mi
from
Boynton Beach, FL
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
Genesis Community Health
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
Pediatrics by the Sea
mi
from
Delray Beach, FL
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
Pediatrics by the Sea
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
Soma Pediatrics
mi
from
Lake Worth, FL
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
Soma Pediatrics
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
Adriana Castro, MD
mi
from
Miami, FL
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
Adriana Castro, MD
mi
from
Miami, FL
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
Lanza Pediatrics
mi
from
Pensacola, FL
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
Lanza Pediatrics
mi
from
Pensacola, FL
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
Northeast Pediatrics
mi
from
St. Petersburg, FL
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
Northeast Pediatrics
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
St. Petersburg Pediatrics
mi
from
St. Petersburg, FL
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
St. Petersburg Pediatrics
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
Teena Hughes, MD
mi
from
Tampa, FL
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
Teena Hughes, MD
mi
from
Tampa, FL
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
Juan E. Batista, MD PA, Pediatric Site #2
mi
from
West Palm Beach, FL
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
Juan E. Batista, MD PA, Pediatric Site #2
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
Soma Medical Center, PA Pediatric Site #3
mi
from
West Palm Beach, FL
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
Soma Medical Center, PA Pediatric Site #3
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
FastER Urgent Care
mi
from
Morris Plains, NJ
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
FastER Urgent Care
mi
from
Morris Plains, NJ
Click here to add this to my saved trials
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated:  12/3/2012
Twelve Corners Pediatrics
mi
from
Rochester, NY
Sofia RSV FIA Field Study
Sofia RSV FIA Field Study
Status: Enrolling
Updated: 12/3/2012
Twelve Corners Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials